Quality of life and resilience in alloSCT- patients

Quality of life and resilience in alloSCT- patients - QUARKS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00007945

Enrollment

Registered

2015-03-27

Start date

2014-03-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing alloSCT

Interventions

Group 1: Patients undergoing alloSCT will be evaluated by use of EORTC QLQ, HADS, Resilience Scale at 3 points of measurement.

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: German language, no psychiatric comorbidity

Exclusion criteria

Exclusion criteria: not fluent in German language, psychiatric comorbidity

Design outcomes

Primary

Measure	Time frame
Quality of life (EORTC Quality of Life Questionnaire), resilience (resilience scale); time points of measurement: 1.: start of treatment, 2.: end of tretament, 3.: 6 months after end of treatment	—

Secondary

Measure	Time frame
anxiety, depression (HADS)	—

Countries

Germany

Contacts

Public ContactAndrea Schumacher

Medizinische Klinik AUniversitätsklinikum

anschum@uni-muenster.de0251 8347601

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026